p21 regulates expression of ECM components and promotes pulmonary fibrosis via CDK4 and Rb
View abstract on PubMed
Summary
This summary is machine-generated.Targeting p21, a cell cycle regulator, may treat age-related fibrosis. Studies show p21 controls extracellular matrix in fibrotic lungs, and its inhibition protects against lung fibrosis in mice.
Area Of Science
- Cell Biology
- Aging Research
- Pulmonary Medicine
Background
- Fibrosis and senescent cell accumulation are hallmarks of aging.
- The cell cycle inhibitor p21 (CDKN1A) is known to regulate senescent cell viability.
Purpose Of The Study
- To investigate the role of p21 in regulating extracellular matrix (ECM) components in the fibrotic lung.
- To determine if targeting p21 can ameliorate lung fibrosis.
Main Methods
- Utilized p21 knockout mice to assess protection against induced lung fibrosis.
- Employed inducible p21 silencing during fibrosis development to evaluate disease alleviation.
- Analyzed inflammatory response, ECM accumulation, and senescent cell populations.
Main Results
- p21 knockout mice were protected from lung fibrosis induction.
- Inducible p21 silencing reduced lung inflammation, ECM deposition, and senescent cells.
- p21 silencing limited fibrosis progression even when initiated post-disease development.
Conclusions
- p21 regulates ECM component expression in both senescent and proliferating cells in fibrotic lungs.
- p21 inhibition represents a potential therapeutic strategy for age-related fibrotic diseases.
Related Concept Videos
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

